GlassScriptPhysician profile
Daniel C Jaffee
NPI 1356346878
$279,778.72
in general payments reported to CMS, 2019-2025
54 companies · $41K in 2025
The $41K reported for 2025 was more than what 98% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $17K · 2021: $27K · 2022: $47K · 2023: $109K · 2024: $27K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $124K · Consulting Fee: $37K · Food and Beverage: $9,031 · Travel and Lodging: $6,687 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $123,850.00 |
| Consulting Fee | $36,825.00 |
| Food and Beverage | $9,031.02 |
| Travel and Lodging | $6,687.19 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $192,998.58 | 2021-2025 | Urolift, Solesta, Barrigel |
| Medtronic, INC. | $39,926.73 | 2021-2025 | Interstim, Altaviva |
| Neotract INC. | $14,084.47 | 2019-2020 | |
| Medtronic USA, INC. | $10,438.12 | 2019-2020 | |
| Boston Scientific Corporation | $9,027.84 | 2019-2024 | Solyx Sis System, Spaceoar Vue System - 10ml, Ams 700 |
| Femselect INC. | $4,939.31 | 2021-2025 | Enplace |
| Lina Medical USA INC | $1,600.00 | 2022 | |
| Pfizer INC. | $776.02 | 2019-2025 | |
| Abbvie INC. | $762.72 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $736.06 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $526.03 | 2019-2025 | Myrbetriq, Xtandi |
| Coloplast Corp | $354.80 | 2019-2024 | Porges Coloplast, Titan, Speedicath |
| Procept Biorobotics Corporation | $312.19 | 2022-2024 | Aquabeam System, Aquabeam Robotic System |
| Janssen Biotech, INC. | $304.26 | 2019-2025 | Erleada |
| Ambu INC. | $294.04 | 2022-2024 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Jaffee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.